{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T09:19:45Z","timestamp":1789809585976,"version":"4.0.1"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1504,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1111\/j.1365-2133.2011.10413.x","type":"journal-article","created":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T02:39:37Z","timestamp":1305599977000},"page":"368-374","source":"Crossref","is-referenced-by-count":78,"title":["Mortality of bullous pemphigoid in Switzerland: a prospective study"],"prefix":"10.1093","volume":"165","author":[{"given":"B.","family":"Cort\u00e9s","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Marazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Naldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Combescure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Borradori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Autoimmune Bullous Disease Swiss Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1001\/archderm.131.8.957","article-title":"Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany","volume":"131","author":"Zillikens","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1001\/archderm.131.1.48","article-title":"Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Bullous Diseases French Study Group","volume":"131","author":"Bernard","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.yadr.2007.07.013","article-title":"Bullous pemphigoid: physiopathology, clinical features and management","volume":"23","author":"Di Zenzo","year":"2007","journal-title":"Adv Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000024364","article-title":"Humoral and cellular autoimmunity in autoimmune bullous skin disorders","volume":"122","author":"Hertl","year":"2000","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(99)03007-X","article-title":"Pemphigus and bullous pemphigoid","volume":"354","author":"Nousari","year":"1999","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0065-2776(08)60503-9","article-title":"Cell adhesion molecules as targets of autoantibodies in pemphigus and pemphigoid, bullous diseases due to defective epidermal cell adhesion","volume":"53","author":"Stanley","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2230.2005.02040.x","article-title":"Clinicoepidemiological features and course of 43 cases of bullous pemphigoid in Kuwait","volume":"31","author":"Nanda","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB8|cit8","first-page":"CR360","article-title":"Epidemiological and clinical analysis of pemphigoid patients in northeastern Poland in 2000-2005","volume":"13","author":"Serwin","year":"2007","journal-title":"Med Sci Monit"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0190-9622(99)70061-7","article-title":"Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence","volume":"41","author":"Jung","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB10|cit10","first-page":"317","article-title":"Bullous pemphigoid in Liguria: a 2-year survey","volume":"15","author":"Cozzani","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1610-0387.2008.06976.x","article-title":"Prospective analysis of the incidence of autoimmune bullous disorders in Lower Franconia, Germany","volume":"7","author":"Bertram","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1365-2133.2005.06662.x","article-title":"Annual incidence and mortality of bullous pemphigoid in the Grampian Region of North-east Scotland","volume":"153","author":"Gudi","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/j.1365-2133.2009.09300.x","article-title":"Incidence of bullous pemphigoid and pemphigus in Switzerland: a 2-year prospective study","volume":"161","author":"Marazza","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"a180","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris - incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jaad.2007.08.010","article-title":"Bullous pemphigoid in infancy: clinical and epidemiologic characteristics","volume":"58","author":"Waisbourd-Zinman","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa011592","article-title":"A comparison of oral and topical corticosteroids in patients with bullous pemphigoid","volume":"346","author":"Joly","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1046\/j.1365-2133.2002.04835.x","article-title":"Guidelines for the management of bullous pemphigoid","volume":"147","author":"Wojnarowska","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1001\/archderm.143.12.1536","article-title":"A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid","volume":"143","author":"Beissert","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/j.1365-2133.2009.09246.x","article-title":"Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid","volume":"161","author":"Gurcan","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archdermatol.2009.53","article-title":"Risk factors for relapse in patients with bullous pemphigoid in clinical remission: a multicenter, prospective, cohort study","volume":"145","author":"Bernard","year":"2009","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/archderm.141.6.691","article-title":"Prediction of survival for patients with bullous pemphigoid: a prospective study","volume":"141","author":"Joly","year":"2005","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1001\/archderm.138.7.903","article-title":"Risk factors for lethal outcome in patients with bullous pemphigoid: low serum albumin level, high dosage of glucocorticosteroids, and old age","volume":"138","author":"Rzany","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1365-2133.1997.tb03654.x","article-title":"Anti-BP180 autoantibodies as a marker of poor prognosis in bullous pemphigoid: a cohort analysis of 94 elderly patients","volume":"136","author":"Bernard","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2307\/2528501","article-title":"Significance factors for the ratio of a Poisson variable to its expectation","volume":"20","author":"Bailar","year":"1964","journal-title":"Biometrics"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/archderm.134.4.465","article-title":"High risk of death in elderly patients with extensive bullous pemphigoid","volume":"134","author":"Roujeau","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB26|cit26","first-page":"751","article-title":"Survival prognosis in pemphigoid. A cohort analysis of 78 patients","volume":"122","author":"Bernard","year":"1995","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.0022-202X.2005.23628.x","article-title":"Sepsis associated with dermatologic hospitalization is not the cause of high mortality of bullous pemphigoid in Europe","volume":"124","author":"Garcia-Doval","year":"2005","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.annder.2009.01.009","article-title":"One year follow-up of patients with bullous pemphigoid","volume":"136","author":"Doffoel-Hantz","year":"2009","journal-title":"Ann Dermatol Venereol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0190-9622(92)70085-T","article-title":"Lack of predictive factors for the clinical course of bullous pemphigoid","volume":"26","author":"Venning","year":"1992","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1111\/j.0022-202X.2004.22504.x","article-title":"Mortality rate of bullous pemphigoid in a US medical center","volume":"122","author":"Colbert","year":"2004","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/archderm.113.8.1043","article-title":"Bullous pemphigoid. Clinical and immunologic follow-up after successful therapy","volume":"113","author":"Ahmed","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1001\/archderm.130.6.753","article-title":"Nicotinamide and tetracycline therapy of bullous pemphigoid","volume":"130","author":"Fivenson","year":"1994","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaad.2008.07.022","article-title":"Mortality of bullous pemphigoid: an evaluation of 223 patients and comparison with the mortality in the general population in the United States","volume":"59","author":"Parker","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1001\/archderm.136.4.521","article-title":"Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?","volume":"136","author":"Chosidow","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000106574","article-title":"Neurological disorders in patients with bullous pemphigoid","volume":"215","author":"Cordel","year":"2007","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB36|cit36","first-page":"230","article-title":"Bullous pemphigoid in a leg affected with hemiparesia: a possible relation of neurological diseases with bullous pemphigoid?","volume":"11","author":"Foureur","year":"2001","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB37|cit37","first-page":"525","article-title":"Bullous pemphigoid and amyotrophic lateral sclerosis","volume":"47","author":"Garcia-Estevez","year":"2008","journal-title":"Rev Neurol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB38|cit38","first-page":"186","article-title":"Multiple sclerosis and bullous pemphigoid: a casual association or a pathogenetic correlation?","volume":"12","author":"Stinco","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1080\/00015550410024481","article-title":"A retrospective epidemiological study on the association of bullous pemphigoid and neurological diseases","volume":"85","author":"Stinco","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/jid.2010.357","article-title":"The relationship between neurological disease and bullous pemphigoid: a population-based case-control study","volume":"131","author":"Langan","year":"2011","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1365-2133.2004.06338.x","article-title":"Bullous pemphigoid antigen 1 isoforms: potential new target autoantigens in multiple sclerosis?","volume":"152","author":"Laffitte","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2011.10413.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1111\/j.1365-2133.2009.09122.x","article-title":"Sera from patients with bullous pemphigoid (BP) associated with neurological diseases recognized BP antigen 1 in the skin and brain","volume":"160","author":"Li","year":"2009","journal-title":"Br J Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2011.10413.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2011.10413.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:52:23Z","timestamp":1676364743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/165\/2\/368\/6644263"}},"subtitle":["Mortality of bullous pemphigoid in Switzerland"],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,8]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10413.x","relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}